Seattle Startup Proprio Obtains Second FDA Clearance for AI Surgical Platform Capturing Intraoperative Data

Seattle startup Proprio received its second FDA clearance for its AI-enabled Paradigm platform, which captures intraoperative measurements to improve surgical precision and outcomes. The technology helps surgeons navigate procedures without radiation and has been used in hundreds of surgeries at institutions like UW Medicine.

GGabriel Jones PProprio